Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant (BMT) With High-dose Post Transplantation Cyclophosphamide.
Phase of Trial: Phase III
Latest Information Update: 23 May 2018
At a glance
- Drugs Hepatitis A vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Cyclophosphamide
- Indications Cancer
- Focus Pharmacodynamics
- 14 Oct 2016 Status changed from active, no longer recruiting to completed.
- 30 Oct 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 21 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.